Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 209

1.

Comparison of VEMPS, VHIT and caloric test outcomes after vestibular neurectomy in Menière's disease.

Canale A, Caranzano F, Lanotte M, Ducati A, Calamo F, Albera A, Lacilla M, Boldreghini M, Lucisano S, Albera R.

Auris Nasus Larynx. 2018 May 7. pii: S0385-8146(17)31024-6. doi: 10.1016/j.anl.2018.04.006. [Epub ahead of print]

PMID:
29747962
2.

The Dominant-Subthalamic Nucleus Phenomenon in Bilateral Deep Brain Stimulation for Parkinson's Disease: Evidence from a Gait Analysis Study.

Rizzone MG, Ferrarin M, Lanotte MM, Lopiano L, Carpinella I.

Front Neurol. 2017 Oct 30;8:575. doi: 10.3389/fneur.2017.00575. eCollection 2017.

3.

The placebo effect on bradykinesia in Parkinson's disease with and without prior drug conditioning.

Frisaldi E, Carlino E, Zibetti M, Barbiani D, Dematteis F, Lanotte M, Lopiano L, Benedetti F.

Mov Disord. 2017 Oct;32(10):1474-1478. doi: 10.1002/mds.27142. Epub 2017 Sep 12.

PMID:
28895186
4.

Deep Brain Stimulation of the subthalamic nucleus does not negatively affect social cognitive abilities of patients with Parkinson's disease.

Enrici I, Mitkova A, Castelli L, Lanotte M, Lopiano L, Adenzato M.

Sci Rep. 2017 Aug 25;7(1):9413. doi: 10.1038/s41598-017-09737-6.

5.

Is Pseudotumor Cerebri An Unusual Expression of Chiari Syndrome? A Case Report and Review of the Literature.

Pacca P, Altieri R, Zenga F, Garbossa D, Ducati A, Lanotte M.

Surg Technol Int. 2017 Jul 25;30:486-489.

PMID:
28537352
6.

Comparison of Allogeneic and Syngeneic Rat Glioma Models by Using MRI and Histopathologic Evaluation.

Biasibetti E, Valazza A, Capucchio MT, Annovazzi L, Battaglia L, Chirio D, Gallarate M, Mellai M, Muntoni E, Peira E, Riganti C, Schiffer D, Panciani P, Lanotte M.

Comp Med. 2017 Mar 1;67(2):147-156.

7.

Prevalence and burden of dysautonomia in advanced Parkinson's disease.

Merola A, Romagnolo A, Comi C, Rosso M, Artusi CA, Zibetti M, Lanotte M, Duker AP, Maule S, Lopiano L, Espay AJ.

Mov Disord. 2017 May;32(5):796-797. doi: 10.1002/mds.26970. Epub 2017 Mar 3. No abstract available.

PMID:
28256092
8.

Solid lipid nanoparticles by coacervation loaded with a methotrexate prodrug: preliminary study for glioma treatment.

Battaglia L, Muntoni E, Chirio D, Peira E, Annovazzi L, Schiffer D, Mellai M, Riganti C, Salaroglio IC, Lanotte M, Panciani P, Capucchio MT, Valazza A, Biasibetti E, Gallarate M.

Nanomedicine (Lond). 2017 Mar;12(6):639-656. doi: 10.2217/nnm-2016-0380. Epub 2017 Feb 10.

PMID:
28186465
9.

Idiopathic delayed-onset edema surrounding deep brain stimulation leads: Insights from a case series and systematic literature review.

de Cuba CM, Albanese A, Antonini A, Cossu G, Deuschl G, Eleopra R, Galati A, Hoffmann CF, Knudsen K, Landi A, Lanotte MM, Marcante A, Mosch A, Pilleri M, Reich MM, Ricchi V, Rinaldo S, Romito LM, Saba FS, Sacristan HE, Schuurman PR, Trezza A, van den Munckhof P, Volkmann J, Zibetti M, Contarino MF.

Parkinsonism Relat Disord. 2016 Nov;32:108-115. doi: 10.1016/j.parkreldis.2016.09.007. Epub 2016 Sep 6. Review.

10.

Impulse control behaviors and subthalamic deep brain stimulation in Parkinson disease.

Merola A, Romagnolo A, Rizzi L, Rizzone MG, Zibetti M, Lanotte M, Mandybur G, Duker AP, Espay AJ, Lopiano L.

J Neurol. 2017 Jan;264(1):40-48. doi: 10.1007/s00415-016-8314-x. Epub 2016 Oct 19.

11.

Progressive gait ataxia following deep brain stimulation for essential tremor: adverse effect or lack of efficacy?

Reich MM, Brumberg J, Pozzi NG, Marotta G, Roothans J, Åström M, Musacchio T, Lopiano L, Lanotte M, Lehrke R, Buck AK, Volkmann J, Isaias IU.

Brain. 2016 Nov 1;139(11):2948-2956. doi: 10.1093/brain/aww223.

12.

Advanced therapies in Parkinson's disease: Long-term retrospective study.

Merola A, Espay AJ, Romagnolo A, Bernardini A, Rizzi L, Rosso M, Espay KJ, Zibetti M, Lanotte M, Lopiano L.

Parkinsonism Relat Disord. 2016 Aug;29:104-8. doi: 10.1016/j.parkreldis.2016.05.015. Epub 2016 May 17.

PMID:
27215392
13.

Teaching neurons to respond to placebos.

Benedetti F, Frisaldi E, Carlino E, Giudetti L, Pampallona A, Zibetti M, Lanotte M, Lopiano L.

J Physiol. 2016 Oct 1;594(19):5647-60. doi: 10.1113/JP271322. Epub 2016 Feb 24.

14.

Role of Nitric Oxide in Glioblastoma Therapy: Another Step to Resolve the Terrible Puzzle ?

Altieri R, Fontanella M, Agnoletti A, Panciani PP, Spena G, Crobeddu E, Pilloni G, Tardivo V, Lanotte M, Zenga F, Ducati A, Garbossa D.

Transl Med UniSa. 2014 Sep 1;12:54-9. eCollection 2015 May-Aug.

15.

Parkinsonism-hyperpyrexia syndrome and deep brain stimulation.

Artusi CA, Merola A, Espay AJ, Zibetti M, Romagnolo A, Lanotte M, Lopiano L.

J Neurol. 2015 Dec;262(12):2780-2. doi: 10.1007/s00415-015-7956-4. Epub 2015 Nov 3. No abstract available.

PMID:
26530506
16.

Earlier versus later subthalamic deep brain stimulation in Parkinson's disease.

Merola A, Romagnolo A, Bernardini A, Rizzi L, Artusi CA, Lanotte M, Rizzone MG, Zibetti M, Lopiano L.

Parkinsonism Relat Disord. 2015 Aug;21(8):972-5. doi: 10.1016/j.parkreldis.2015.06.001. Epub 2015 Jun 4.

PMID:
26060146
17.

Characterization of crumb rubber from end-of-life tyres for paving applications.

Zanetti MC, Fiore S, Ruffino B, Santagata E, Dalmazzo D, Lanotte M.

Waste Manag. 2015 Nov;45:161-70. doi: 10.1016/j.wasman.2015.05.003. Epub 2015 Jun 6.

PMID:
26050935
18.

Vagus nerve stimulation for treatment-resistant mood disorders: a long-term naturalistic study.

Albert U, Maina G, Aguglia A, Vitalucci A, Bogetto F, Fronda C, Ducati A, Lanotte M.

BMC Psychiatry. 2015 Mar 31;15:64. doi: 10.1186/s12888-015-0435-8.

19.

Instrumented gait analysis for an objective pre-/postassessment of tap test in normal pressure hydrocephalus.

Agostini V, Lanotte M, Carlone M, Campagnoli M, Azzolin I, Scarafia R, Massazza G, Knaflitz M.

Arch Phys Med Rehabil. 2015 Jul;96(7):1235-41. doi: 10.1016/j.apmr.2015.02.014. Epub 2015 Feb 27.

20.

Are acute subdural hematomas possible without head trauma?

Garbossa D, Altieri R, Specchia FM, Agnoletti A, Pilloni G, Lanotte M, Spaziante R, Ducati A.

Asian J Neurosurg. 2014 Oct-Dec;9(4):218-22. doi: 10.4103/1793-5482.146612.

21.

Positive-charged solid lipid nanoparticles as paclitaxel drug delivery system in glioblastoma treatment.

Chirio D, Gallarate M, Peira E, Battaglia L, Muntoni E, Riganti C, Biasibetti E, Capucchio MT, Valazza A, Panciani P, Lanotte M, Annovazzi L, Caldera V, Mellai M, Filice G, Corona S, Schiffer D.

Eur J Pharm Biopharm. 2014 Nov;88(3):746-58.

22.

Alexithymia in patients with Parkinson's disease treated with DBS of the subthalamic nucleus: a case-control study.

Castelli L, Tonello D, Rizzi L, Zibetti M, Lanotte M, Lopiano L.

Front Psychol. 2014 Oct 13;5:1168. doi: 10.3389/fpsyg.2014.01168. eCollection 2014.

23.

Does intraoperative microrecording really increase the risk of hemorrhagic complications in deep brain stimulation?

Zibetti M, Romagnolo A, Crobeddu E, Fornaro R, Merola A, Rizzone MG, Lopiano L, Lanotte M.

Brain Stimul. 2014 Nov-Dec;7(6):911-2. doi: 10.1016/j.brs.2014.07.037. Epub 2014 Jul 26. No abstract available.

24.

Stimulation of the subthalamic area modulating movement and behavior.

Ricciardi L, Morgante L, Epifanio A, Zibetti M, Lanotte M, Lopiano L, Morgante F.

Parkinsonism Relat Disord. 2014 Nov;20(11):1298-300. doi: 10.1016/j.parkreldis.2014.07.013. Epub 2014 Aug 9. No abstract available.

25.

Molecular biology of gliomas: present and future challenges.

Altieri R, Agnoletti A, Quattrucci F, Garbossa D, Calamo Specchia FM, Bozzaro M, Fornaro R, Mencarani C, Lanotte M, Spaziante R, Ducati A.

Transl Med UniSa. 2014 Apr 8;10:29-37. eCollection 2014 Sep. Review.

26.

Subthalamic deep brain stimulation: clinical and neuropsychological outcomes in mild cognitive impaired parkinsonian patients.

Merola A, Rizzi L, Artusi CA, Zibetti M, Rizzone MG, Romagnolo A, Bernardini A, Lanotte M, Lopiano L.

J Neurol. 2014 Sep;261(9):1745-51. doi: 10.1007/s00415-014-7414-8. Epub 2014 Jun 22.

27.

Solid lipid nanoparticles for potential doxorubicin delivery in glioblastoma treatment: preliminary in vitro studies.

Battaglia L, Gallarate M, Peira E, Chirio D, Muntoni E, Biasibetti E, Capucchio MT, Valazza A, Panciani PP, Lanotte M, Schiffer D, Annovazzi L, Caldera V, Mellai M, Riganti C.

J Pharm Sci. 2014 Jul;103(7):2157-2165. doi: 10.1002/jps.24002. Epub 2014 May 13.

28.

Characterization of the thalamic-subthalamic circuit involved in the placebo response through single-neuron recording in Parkinson patients.

Frisaldi E, Carlino E, Lanotte M, Lopiano L, Benedetti F.

Cortex. 2014 Nov;60:3-9. doi: 10.1016/j.cortex.2013.12.003. Epub 2013 Dec 24. Review.

29.

Medical therapy and subthalamic deep brain stimulation in advanced Parkinson's disease: a different long-term outcome?

Merola A, Rizzi L, Zibetti M, Artusi CA, Montanaro E, Angrisano S, Lanotte M, Rizzone MG, Lopiano L.

J Neurol Neurosurg Psychiatry. 2014 May;85(5):552-9. doi: 10.1136/jnnp-2013-305271. Epub 2013 Jul 11.

30.

Pontine compression caused by "surgiceloma" after trigeminal decompression: case report and literature review.

Boeris D, Evins AI, Lanotte MM, Zeme S, Ducati A.

Acta Neurol Belg. 2014 Sep;114(3):229-31. doi: 10.1007/s13760-013-0203-9. Epub 2013 May 1. Review. No abstract available.

31.

Activation of both protein kinase A (PKA) type I and PKA type II isozymes is required for retinoid-induced maturation of acute promyelocytic leukemia cells.

Nguyen E, Gausdal G, Varennes J, Pendino F, Lanotte M, Døskeland SO, Ségal-Bendirdjian E.

Mol Pharmacol. 2013 May;83(5):1057-65. doi: 10.1124/mol.112.081034. Epub 2013 Mar 1.

32.

Cyclic AMP can promote APL progression and protect myeloid leukemia cells against anthracycline-induced apoptosis.

Gausdal G, Wergeland A, Skavland J, Nguyen E, Pendino F, Rouhee N, McCormack E, Herfindal L, Kleppe R, Havemann U, Schwede F, Bruserud O, Gjertsen BT, Lanotte M, Ségal-Bendirdjian E, Døskeland SO.

Cell Death Dis. 2013 Feb 28;4:e516. doi: 10.1038/cddis.2013.39.

33.

80 Hz versus 130 Hz subthalamic nucleus deep brain stimulation: effects on involuntary movements.

Merola A, Zibetti M, Artusi CA, Rizzi L, Angrisano S, Lanotte M, Lopiano L, Rizzone MG.

Parkinsonism Relat Disord. 2013 Apr;19(4):453-6. doi: 10.1016/j.parkreldis.2013.01.006. Epub 2013 Feb 8.

34.

Impulsivities and Parkinson's disease: delay aversion is not worsened by Deep Brain Stimulation of the subthalamic nucleus.

Torta DM, Vizzari V, Castelli L, Zibetti M, Lanotte M, Lopiano L, Geminiani G.

PLoS One. 2012;7(9):e43261. doi: 10.1371/journal.pone.0043261. Epub 2012 Sep 11.

35.

Stem cells based therapy in high grade glioma: why the intraventricular route should be preferred?

Panciani PP, Fontanella M, Tamagno I, Battaglia L, Garbossa D, Inghirami G, Fagioli F, Pagano M, Ducati A, Lanotte M.

J Neurosurg Sci. 2012 Sep;56(3):221-9.

PMID:
22854590
36.

Central neuropathic itch as the presenting symptom of an intramedullary cavernous hemangioma: case report and review of literature.

Lanotte M, Panciani PP, Magistrello M, Naldi A, Fontanella M, Ducati A, Giordana MT.

Clin Neurol Neurosurg. 2013 Apr;115(4):454-6. doi: 10.1016/j.clineuro.2012.05.028. Epub 2012 Jun 17. No abstract available.

37.

5-aminolevulinic acid and neuronavigation in high-grade glioma surgery: results of a combined approach.

Panciani PP, Fontanella M, Garbossa D, Agnoletti A, Ducati A, Lanotte M.

Neurocirugia (Astur). 2012 Feb;23(1):23-8. doi: 10.1016/j.neucir.2012.04.003.

PMID:
22520100
38.

Subthalamic nucleus deep brain stimulation outcome in young onset Parkinson's disease: a role for age at disease onset?

Merola A, Zibetti M, Artusi CA, Marchisio A, Ricchi V, Rizzi L, Angrisano S, Arduino N, Lanotte M, Rizzone M, Lopiano L.

J Neurol Neurosurg Psychiatry. 2012 Mar;83(3):251-7. doi: 10.1136/jnnp-2011-300470. Epub 2011 Dec 16.

39.

Beyond nine years of continuous subthalamic nucleus deep brain stimulation in Parkinson's disease.

Zibetti M, Merola A, Rizzi L, Ricchi V, Angrisano S, Azzaro C, Artusi CA, Arduino N, Marchisio A, Lanotte M, Rizzone M, Lopiano L.

Mov Disord. 2011 Nov;26(13):2327-34. doi: 10.1002/mds.23903. Epub 2011 Aug 25.

PMID:
22012750
40.

Fluorescence and image guided resection in high grade glioma.

Panciani PP, Fontanella M, Schatlo B, Garbossa D, Agnoletti A, Ducati A, Lanotte M.

Clin Neurol Neurosurg. 2012 Jan;114(1):37-41. doi: 10.1016/j.clineuro.2011.09.001. Epub 2011 Sep 29.

41.

Antigenic and Genotypic Similarity between Primary Glioblastomas and Their Derived Neurospheres.

Caldera V, Mellai M, Annovazzi L, Piazzi A, Lanotte M, Cassoni P, Schiffer D.

J Oncol. 2011;2011:314962. doi: 10.1155/2011/314962. Epub 2011 Aug 18.

42.

Transient effects of 80 Hz stimulation on gait in STN DBS treated PD patients: a 15 months follow-up study.

Ricchi V, Zibetti M, Angrisano S, Merola A, Arduino N, Artusi CA, Rizzone M, Lopiano L, Lanotte M.

Brain Stimul. 2012 Jul;5(3):388-392. doi: 10.1016/j.brs.2011.07.001. Epub 2011 Jul 31.

43.

Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients.

Merola A, Zibetti M, Angrisano S, Rizzi L, Ricchi V, Artusi CA, Lanotte M, Rizzone MG, Lopiano L.

Brain. 2011 Jul;134(Pt 7):2074-84. doi: 10.1093/brain/awr121. Epub 2011 Jun 11.

44.

Comparison of subthalamic nucleus deep brain stimulation and Duodopa in the treatment of advanced Parkinson's disease.

Merola A, Zibetti M, Angrisano S, Rizzi L, Lanotte M, Lopiano L.

Mov Disord. 2011 Mar;26(4):664-70. doi: 10.1002/mds.23524. Epub 2011 Apr 5.

PMID:
21469197
45.

A computational model to compare different investment scenarios for mini-stereotactic frame approach to deep brain stimulation surgery.

Lanotte M, Cavallo M, Franzini A, Grifi M, Marchese E, Pantaleoni M, Piacentino M, Servello D.

J Neurosurg Sci. 2010 Sep;54(3):91-7.

PMID:
21423075
46.

Surgical indication in Menière's disease therapy: clinical and epidemiological aspects.

Albera R, Canale A, Parandero F, Ducati A, Lanotte M.

Eur Arch Otorhinolaryngol. 2011 Jul;268(7):967-72. doi: 10.1007/s00405-011-1490-5. Epub 2011 Jan 19.

47.

Probable REM sleep behaviour disorder and STN-DBS outcome in Parkinson's Disease.

Zibetti M, Rizzi L, Colloca L, Cinquepalmi A, Angrisano S, Castelli L, Lanotte M, Lopiano L.

Parkinsonism Relat Disord. 2010 May;16(4):265-9. doi: 10.1016/j.parkreldis.2010.01.001. Epub 2010 Feb 11.

PMID:
20153238
48.

Asymptomatic deep venous thrombosis after deep brain stimulation for Parkinson disease.

Zibetti M, Rosso M, Cinquepalmi A, Lanotte M, Angrisano S, Rabbia C, Valpreda S, Lopiano L.

Stereotact Funct Neurosurg. 2010;88(2):94-7. doi: 10.1159/000280821. Epub 2010 Feb 5.

PMID:
20134208
49.

Management of antiparkinsonian therapy during chronic subthalamic stimulation in Parkinson's disease.

Zibetti M, Cinquepalmi A, Angrisano S, Lanotte M, Lopiano L.

Parkinsonism Relat Disord. 2009 Dec;15 Suppl 4:S76-80. doi: 10.1016/S1353-8020(09)70840-5.

PMID:
20123562
50.

Epigenetic plasticity of hTERT gene promoter determines retinoid capacity to repress telomerase in maturation-resistant acute promyelocytic leukemia cells.

Azouz A, Wu YL, Hillion J, Tarkanyi I, Karniguian A, Aradi J, Lanotte M, Chen GQ, Chehna M, Ségal-Bendirdjian E.

Leukemia. 2010 Mar;24(3):613-22. doi: 10.1038/leu.2009.283. Epub 2010 Jan 14.

PMID:
20072159

Supplemental Content

Loading ...
Support Center